Does eosinophilia predict clozapine induced neutropenia?

Psychopharmacology

Volumn 124, Issue 1-2, 1996, Pages 201-204

  Hummer, Martina ^a   Sperner Unterweger, Barbara ^a   Kemmler, Georg ^a   Falk, Markus ^b   Kurz, Martin ^a   Oberbauer, Harald ^a   Fleischhacker, W Wolfgang ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Agranulocytosis; Clozapine; Eosinophilia; Haloperidol; Neutropenia

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PREDICTION; PRIORITY JOURNAL; RISK; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; CLOZAPINE; EOSINOPHILIA; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; PROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 0029879780     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02245622     Document Type: Article

References (24)

1. Abt K, Gülich A, Krupp P, Reinberg W (1992) HLA-association in Leponex/Clozaril (clozapine)-induced granulocytopenia and agranulocytosis: statistical viewpoints. Drug Safety [Suppl 1]:10-16
2. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA (1993) Clozapine-induced agranulocytosis. N Engl J Med 329:162-167
3. Banov MD, Tohen M, Friedberg J (1993) High risk of eosinophilia in women treated with clozapine. J Clin Psychiatry 54:466-469
4. Bender JE, Van Epps DE, Stewart CC (1987) Regulation of myelopoiesis. Comp Immunol Microbiol Infect Dis 10:79-91
5. Claas FHJ, Abbott PA, Witvliet MD, D'Amaro J, Barnes PM, Krupp P (1992) No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis. Drug Safety 7 [Suppl 1]:3-6
6. Fischer V, Haar JA, Greiner L, Loyd RV, Mason RP (1991) Possible role of free radical formation in clozapine (Clozaril)-induced agranulocytosis. Mol Pharmacol 40:846-853
7. Frankenburg FR, Kando J (1992) Eosinophilia, clozapine, and pancreatitis. Lancet 340:251
8. Gerson SL, Meltzer J (1992) Mechanisms of clozapine-induced agranulocytosis. Drug Safety 7 (Suppl 1):17-25
9. Hoffbrand AV (1992a). Concluding remarks. Drug Safety 7 (Suppl 1):60
10. Hoffbrand AV (1992b) Round-table discussion. Drug Safety (Suppl 1):57-59
11. Hummer M, Kurz M, Barnas C, Fleischhacker WW (1992) Transient neutropenia induced by clozapine. Psychopharmacol Bull 28:287-290
12. Hummer M, Kurz M, Barnas C, Saria A, Fleischhacker WW (1994) Clozapine-induced transient white blood count disorders. J Clin Psychiatry 55:429-432
13. Krupp P, Barnes P (1992) Clozapine-associated agranulocytosis: risk and aetiology. Br J Psychiatry 160 [Suppl 17]:38-40
14. Lieberman JA, Johns CA, Kane JM, Rai K, Pisciotta AV, Saltz BL, Howard A (1988) Clozapine-induced agranulocytosis: non-cross reactivity with other psychotropic drugs. J Clin Psychiatry 49:271-277
15. Pfister GM, Hanson DR, Roerig JL, Landbloom R, Popkin MK (1992) Clozapine-induced agranulocytosis in a native American: HLA typing and further support for an immune-mediated mechanism. J Clin Psychiatry 53:242-244
16. Pisciotta AV, Konings SA, Ciesemier LL, Cronkite CE, Lieberman JA (1992) On the possible mechanisms and predictability of clozapine-induced agranulocytosis. Drug Safety 7 (Suppl 11:33-44
17. Pisciotta AV, Konings SA, Ciesemier LL et al. (1992) Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis. J Lab Clin Med 119:254-266
18. Ruef C, Coleman DL (1991) GM-CSF and G-CSF: Zytokine in der klinischen Anwendung. Schweiz, Med Wschr 121:397-412
19. Safferman AZ, Lieberman JA, Alvir JMJ, Howard A (1992) Rechallenge in clozapine-induced agranulocytosis. Lancet 339:1296-1297
20. Steel RGD, Torrie JH (1981) Principles and procedures of statistics - a biometrical approach. McGraw Hill, London, pp 280-282
21. Stricker BH, Tielens JAE (1991) Eosinophilia with clozapine. Lancet 338:1520-1521
22. Tiihonen J, Paanila J (1992) Eosinophilia associated with clozapine. Lancet 339:488
23. Veys PA, Wilkes S, Shah S, Noyelle R, Hoffbrand AV (1992) Clinical experience of clozapine-induced neutropenia in UK: laboratory investigation using liquid culture systems and immunofluorocytometry. Drug Safety 7 (Suppl 1):26-32
24. Yunis JJ, Lieberman J, Yunis EJ (1992) Major histocompatibility complex associations with clozapine-induced agranulocytosis: the USA experience. Drug Safety 7 (Suppl 1):7-9